Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: , HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 62.2;U-266/70: 42.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"			280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.4	0.5	3.5	14.4	7.2	7.4	0.7	3.8	8.6	2.9	18.1	4.3	0.7	3.5	4.6	3.4	9.7	2.3	23.6	5.5	3.0	2.2	6.7	2.7	7.4	6.8	2.4	7.8	6.8	3.3	0.3	5.9	1.3	4.6	18.8	2.5	3.5	2.8	8.1	5.4	3.9	2.4	0.4	62.2	0.4	1.0	9.2	16.4	2.2	17.7	0.1	9.6	5.5	0.9	0.3	1.4	0.5	0.6	42.9	12.3	2.6	28.1	7.0	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	18	"HEL: 27.6;K-562: 15.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA060228: , HPA069636: "	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	27.6	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: "	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favourable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.1	15.1	5.8	7.0	24.8	16.8	8.7	9.8	17.7	11.2	11.1	20.7	19.0	15.8	19.8	16.5	24.1	8.8	23.4	4.8	18.6	10.3	13.4	14.3	28.5	17.2	9.1	37.7	17.9	24.9	18.3	8.8	11.8	11.2	6.4	5.2	14.7	13.8	31.8	3.6	9.8	13.5	8.8	7.7	10.4	22.8	6.0	12.3	7.1	10.6	31.6	9.3	20.8	14.0	15.9	11.0	16.1	6.0	10.3	5.0	8.3	8.4	13.7	8.4	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323051-30338227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"				"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: , HPA048127: AB_2680277"	"prognostic favourable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (7.49e-4)"	13.9	21.5	24.5	12.9	29.1	6.3	18.7	22.7	23.4	17.0	14.5	8.0	22.4	8.7	18.1	22.7	11.1	15.8	12.4	20.5	17.7	15.5	16.5	17.6	10.3	23.5	15.5	20.5	20.1	15.0	33.4	28.6	10.6	15.1	19.0	10.3	9.0	17.0	19.9	28.0	11.6	12.5	18.3	16.0	18.2	14.4	14.5	15.0	11.6	23.3	13.9	19.1	16.1	15.1	17.6	12.7	5.5	9.6	24.4	28.7	11.2	5.7	8.3	9.3	8.2	15.3	16.6	4.7	11.2	14.2	10.2	11.3	4.6	2.2	23.4	7.7	8.1	9.7	13.5	9.5	14.5	18.5	16.8	7.0	6.6	8.0	24.1	12.6	8.1	17.2	19.2	4.8	18.3	11.2	11.1	12.8	17.8	5.4	11.3	10.4	10.8	11.6	10.0	22.8	9.5	13.7	8.0	10.6	11.3	8.8	11.7	13.8	12.5	7.1	9.8	11.7	6.2	23.0	10.6	20.0	11.3	15.2	11.2	7.9	11.1	5.5	9.6	3.0	12.1	9.4	28.7	17.6	14.8	13.4	12.7	14.0	13.7	13.1	1.7	24.4	7.0	9.1	9.5	11.2	24.5	29.1	22.7	23.4	17.7	15.5	15.5	20.5	15.1	15.0
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"			15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	50.8	28.2	24.3	16.7	20.1	28.7	58.2	69.9	53.9	30.5	24.9	25.5	36.1	46.8	79.6	40.2	35.4	17.1	23.8	16.1	67.4	15.3	28.3	38.4	22.0	32.7	41.0	55.2	34.7	25.4	36.9	29.4	35.7	21.5	38.8	39.5	20.9	38.2	11.0	23.2	10.8	35.6	21.6	45.2	17.1	26.4	10.5	28.3	72.9	31.5	27.0	31.6	36.7	79.5	44.6	23.2	49.8	67.3	46.3	51.1	32.0	35.1	29.6	34.2	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.8;RH-30: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: "	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	1.9	1.5	1.9	2.2	2.8	2.7	1.0	1.9	1.9	2.2	2.1	1.2	2.4	6.8	2.4	1.4	1.8	1.8	1.9	3.8	3.4	1.8	4.4	1.2	1.9	1.2	8.9	3.0	1.4	1.5	1.3	0.5	1.5	4.6	4.9	1.8	3.0	4.8	14.8	1.6	3.7	3.1	48.8	2.8	1.8	2.5	1.2	1.8	3.0	2.8	1.5	4.9	8.4	0.8	1.6	2.8	2.1	1.8	4.0	2.1	3.5	1.8	9.6	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"			21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favourable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.5	13.5	8.3	14.8	14.0	12.1	4.8	4.6	8.6	9.9	13.0	8.6	14.7	1.2	8.5	9.5	14.2	12.7	7.8	11.5	10.1	13.4	10.5	10.2	6.8	8.6	4.5	19.2	9.0	11.3	15.8	6.8	7.0	38.1	41.4	14.7	5.6	1.8	4.0	5.3	0.1	0.1	8.6	18.2	11.4	5.2	22.9	12.2	7.2	6.6	13.7	15.9	6.8	4.1	8.4	0.3	12.3	5.5	16.9	22.9	2.5	11.3	0.1	9.8	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"				"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.4	15.2	9.5	16.5	22.1	14.8	17.6	13.7	23.5	10.7	12.8	4.6	20.2	9.8	29.2	20.2	16.0	9.5	12.7	5.0	14.3	9.4	10.0	8.6	11.4	32.1	11.7	12.0	17.8	13.8	14.1	29.0	10.3	14.7	17.0	10.4	21.6	5.4	7.8	7.4	10.0	12.4	14.3	29.7	12.2	7.1	10.4	16.0	10.3	27.2	21.4	23.5	17.3	8.9	18.7	10.5	12.0	8.9	24.8	14.4	7.4	23.9	18.0	25.7	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506588-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023654, HPA052426, HPA052428, HPA061371"	Approved		Approved	"Nucleoplasm,Vesicles,Mitotic spindle,Centrosome"				Nucleoplasm	"Vesicles, Mitotic spindle, Centrosome"	"HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: "	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (5.78e-4)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	13.0	8.6	10.9	17.1	13.1	37.9	15.5	27.9	15.6	16.7	14.2	16.2	11.6	11.9	26.5	16.6	10.7	17.1	12.3	10.6	11.5	7.8	14.1	11.7	13.0	20.7	13.6	7.9	27.3	15.5	11.8	20.4	8.5	13.0	15.2	13.5	15.6	13.8	19.8	14.6	21.7	14.2	15.0	17.4	13.2	13.3	16.9	13.9	26.4	21.0	8.6	14.7	14.3	14.0	5.9	3.7	2.2	3.6	2.1	10.8	2.4	10.0	6.4	13.1	11.3	3.5	9.0	13.1	5.1	5.2	6.4	9.7	7.7	5.8	16.1	3.4	7.2	12.8	11.2	9.9	13.2	4.2	8.6	14.3	12.4	14.8	11.6	15.5	7.7	10.2	10.4	7.1	15.9	5.4	16.4	11.8	7.0	11.8	19.6	9.9	8.1	8.0	14.1	23.7	11.9	7.4	16.1	8.3	15.0	7.0	10.3	13.3	11.4	10.4	8.0	14.6	11.4	6.7	6.9	12.0	9.6	17.1	6.3	11.9	8.9	2.2	3.6	2.2	4.5	2.9	10.8	4.5	5.2	4.5	3.4	5.9	8.0	5.4	1.4	2.1	3.4	3.7	4.2	2.4	10.9	13.1	27.9	15.6	11.5	7.8	13.6	7.9	13.0	13.9
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.4	82.1	61.5	33.3	8.9	9.1	49.2	27.7	21.5	60.1	48.2	79.3	88.0	56.7	47.4	18.3	55.2	61.0	39.7	56.5	50.9	39.5	38.3	36.5	55.7	2.7	46.1	35.3	5.3	17.2	51.4	71.3	30.1	62.2	77.1	45.2	59.2	43.2	35.6	78.0	74.1	43.5	50.7	72.6	21.4	21.8	25.1	63.4	41.9	39.7	45.8	53.1	64.6	16.8	39.1	40.5	32.2	65.9	47.6	92.3	80.0	24.8	39.3	53.9	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	86.6	74.3	45.5	30.4	13.4	12.2	33.2	51.6	27.9	57.2	45.8	30.5	43.0	64.9	30.6	19.3	61.0	54.5	39.7	65.8	50.6	44.1	32.9	54.4	80.9	5.8	67.0	37.5	4.4	9.2	40.9	36.2	52.9	39.2	56.9	73.2	65.0	52.6	118.1	66.4	68.6	45.6	50.0	38.7	44.9	19.9	38.5	22.9	42.8	41.6	41.6	50.1	39.0	30.0	24.7	47.0	59.7	75.0	46.1	93.5	52.4	36.5	38.8	35.2	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"			51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: "	"unprognostic (1.56e-1)"	"prognostic unfavourable (7.35e-4)"	"prognostic favourable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	46.9	71.1	35.1	34.7	59.3	48.3	40.1	50.5	53.3	45.3	47.3	43.5	28.9	32.7	58.0	71.7	31.0	52.2	42.0	60.5	35.1	28.1	53.6	45.0	67.5	45.2	36.6	31.0	45.7	25.7	68.8	44.4	50.0	53.3	46.3	70.5	83.7	21.7	10.9	30.2	41.5	19.3	58.8	39.6	50.7	66.7	31.5	37.5	31.3	20.5	29.9	48.7	23.1	63.9	83.1	49.6	39.6	51.7	36.5	51.2	30.2	60.9	24.8	50.7	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"			34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: "	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (2.19e-6)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	128.4	28.3	9.6	11.0	16.2	25.3	15.8	27.5	27.5	24.3	19.2	37.4	32.4	5.0	27.3	35.2	28.6	11.4	28.9	17.8	10.1	11.5	0.5	21.1	17.5	35.0	0.1	6.8	35.7	20.4	26.8	15.2	20.3	14.4	0.9	23.9	35.1	0.2	1.8	10.4	17.3	0.0	11.8	4.0	27.1	41.9	7.9	13.5	20.1	27.6	45.7	22.5	0.5	25.3	21.4	13.7	33.2	18.3	2.2	1.4	0.3	42.7	0.1	29.2	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				"Nucleoli, Vesicles"	"Nucleoplasm, Cytosol"	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.0	30.5	4.9	14.1	23.2	15.4	4.1	9.1	13.9	11.0	11.0	8.3	20.2	35.2	16.4	16.0	25.3	4.6	25.4	6.7	23.5	10.4	6.0	20.6	5.6	10.9	8.3	15.8	21.6	35.9	23.9	11.0	16.3	19.8	21.1	18.5	19.4	15.7	3.6	9.1	17.5	19.0	4.7	26.3	12.7	17.9	6.0	10.0	18.6	26.9	21.0	21.8	9.7	10.9	13.0	6.7	12.6	13.1	13.2	17.4	19.7	17.8	14.6	16.3	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge"				"Nucleoplasm, Nuclear bodies, Vesicles"	"Cytokinetic bridge"	"HPA059516: , HPA060569: , HPA069538: "	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	3.9	6.4	6.8	7.0	4.0	3.4	55.0	5.8	4.1	6.7	6.5	8.8	4.4	11.0	3.7	4.2	3.3	8.9	5.1	7.7	9.0	6.4	9.5	5.8	8.0	9.0	8.9	7.7	4.5	9.1	9.6	6.5	6.6	10.1	8.2	5.5	8.1	8.8	5.0	12.2	6.7	8.1	5.6	6.1	5.8	6.9	7.0	12.3	7.1	6.6	6.7	9.9	7.1	6.4	7.0	5.2	6.2	8.3	10.8	21.6	11.6	6.8	10.7	8.3	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"	Q2M3D2	19	45212621-45245431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 17.8;K-562: 16.4"									"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.5"									"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: "																		3.2	4.3	0.0	2.0	0.0	0.9	3.0	0.0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0.0		12.7	9.4	3.4	6.3	0.0	0.0	3.4	2.8	2.4	3.5	0.4	0.0	3.7	0.2	13.7	3.3	3.6	1.0	2.4	3.9	1.6	0.0	12.6	2.4	2.1	0.0	0.0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.1	0.0	1.1	0.0	0.1	0.0	0.1	0.0	17.8	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.4	0.3	0.0	0.2	0.0	0.0	0.2	0.5	1.2	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0.0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2										
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: , HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.7	2.1	17.3	0.0	0.0	0.0	6.4	2.2	1.5	1.6	3.0	0.0	2.1	0.0	6.2	2.4	0.8	5.7	2.4	1.3	0.0	4.3	0.0	4.0	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.5	3.7	0.0	0.0	4.7	1.4	0.0	0.0	7.3	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	1.8	0.0	0.3	7.2	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"				"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	18.3	6.4	10.1	19.9	10.7	5.0	13.8	8.5	11.2	9.3	8.0	23.2	6.3	6.0	13.5	20.8	5.1	7.5	13.0	12.6	10.6	9.0	10.1	3.1	18.0	22.5	14.0	7.7	18.9	3.8	3.7	5.0	14.4	12.9	7.5	6.2	9.8	5.0	5.1	6.3	4.8	10.7	12.3	14.2	13.0	6.7	10.5	11.3	16.2	15.0	5.1	27.9	9.6	7.7	1.7	8.6	3.6	0.7	1.1	1.5	0.7	4.4	1.3	10.0	3.3	2.8	11.3	0.1	5.5	11.3	7.6	6.7	5.1	1.2	9.6	10.7	6.6	0.2	5.1	2.3	7.0	8.4	1.9	10.5	1.5	0.2	4.9	2.1	13.8	7.1	0.3	11.8	5.0	20.0	2.3	7.1	11.1	3.3	8.5	3.1	3.3	2.9	4.1	12.5	1.4	7.1	0.6	1.7	4.7	3.2	0.4	6.5	0.8	3.1	25.2	18.9	6.6	0.3	9.5	3.7	0.2	5.2	11.7	6.5	7.9	3.6	0.3	1.2	1.5	0.7	0.7	0.4	0.5	0.9	0.4	1.7	0.8	0.9	0.0	1.1	0.6	8.6	0.3	0.7	10.1	10.7	8.5	11.2	10.6	9.0	14.0	7.7	12.9	11.3
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell line enhanced"	"Detected in some"		"A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"			630000	"Nucleoli, Golgi apparatus, Cytosol"	Vesicles	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.1	2.5	0.0	0.0	1.0	8.1	0.0	15.2	27.2	0.2	0.6	1.0	13.4	0.0	0.0	31.7	27.1	0.4	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.5	0.0	15.7	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Group enriched"	"Detected in some"	9	"PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.8	5.5	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	0.0	3.0	0.0	84.9	57.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: "	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	93.4	41.7	0.6	3.9	17.7	2.8	4.2	0.8	0.4	0.0	2.9	7.8	0.7	0.0	0.3	2.3	7.7	0.0	0.1	0.4	4.3	29.3	0.0	0.0	115.0	0.3	3.1	0.7	1.2	0.4	0.1	4.0	0.7	0.0	0.1	0.1	0.1	0.0	0.2	0.0	2.6	1.9	0.0	0.0	1.7	1.1	0.0	1.6	0.1	0.0	8.0	0.5	13.4	0.3	0.0	0.0	0.0	3.1	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.6	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	10.6	0.0	3.4	1.5	0.0	0.2	4.1	0.0	0.0	0.1	0.6	8.5	0.2	0.2	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.2	0.6	12.7	0.1	0.6	0.7	0.0	3.3	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.6	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: , HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	1.1	1.8	0.0	0.3	0.3	2.1	0.6	2.9	0.2	0.3	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.0	0.5	0.5	1.1	1.5	0.0	0.7	7.4	0.9	0.0	0.4	7.0	4.3	0.4	0.4	0.0	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	0.9	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: "	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favourable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	69.8	10.0	8.4	26.3	10.6	80.6	101.1	7.4	10.1	28.6	31.7	10.3	9.7	11.0	24.9	28.8	38.6	28.0	38.6	18.6	7.8	5.1	32.2	32.5	46.0	35.8	13.8	4.2	20.2	23.8	7.5	4.7	26.1	11.2	20.1	21.0	13.2	26.9	16.5	57.8	60.2	44.8	42.8	17.0	20.3	26.7	14.3	10.0	12.5	41.0	28.8	21.5	44.7	30.7	15.6	29.8	77.8	18.7	13.0	30.8	23.2	13.0	3.5	6.8	2.2	39.6	39.8	4.3	22.5	11.5	24.1	16.4	9.1	17.6	3.7	5.2	24.3	7.9	4.2	20.7	20.1	18.3	2.5	0.5	4.1	8.6	17.0	2.4	12.9	13.1	39.6	17.1	32.7	24.5	4.1	29.2	30.5	0.9	4.5	3.8	2.5	6.4	3.0	7.0	13.1	23.6	13.0	3.0	2.9	5.5	16.0	33.7	7.9	2.0	31.9	32.5	4.5	19.2	10.3	5.6	18.2	6.9	8.7	3.3	10.0	50.9	17.0	43.7	27.1	14.2	23.9	15.6	30.8	26.8	13.1	12.5	9.6	14.8	77.8	13.0	18.7	29.8	22.2	23.2	8.4	10.6	7.4	10.1	7.8	5.1	13.8	4.2	11.2	10.0
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_10600302, HPA027270: AB_10600884"	"unprognostic (1.05e-2)"	"prognostic favourable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.4	22.0	2.2	3.9	1.5	3.7	5.6	2.6	1.8	8.3	5.1	3.4	11.6	4.2	13.3	2.7	6.6	1.0	3.5	4.3	22.6	1.7	0.9	6.0	1.5	4.0	0.7	4.4	5.8	2.2	4.1	2.2	1.6	1.8	18.0	4.2	3.4	3.9	1.5	1.2	3.1	5.2	6.7	9.5	6.0	1.9	2.3	1.9	4.0	2.7	2.8	1.7	0.4	3.5	3.8	5.9	3.2	22.1	17.2	6.4	2.2	2.1	2.4	5.1	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3										
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"		20	58981208-58995133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262"			Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: , HPA066262: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	9.1	11.1	10.2	9.4	13.0	8.8	12.7	18.1	13.7	10.2	10.8	15.2	9.2	8.4	11.2	8.2	14.6	12.5	8.6	9.2	10.9	8.2	16.4	15.9	7.9	11.2	16.7	13.4	15.4	10.3	19.1	18.1	12.1	12.5	10.2	8.9	9.4	14.7	9.1	12.0	11.9	8.8	8.1	11.8	9.2	8.9	26.1	12.4	17.4	14.4	10.0	13.6	9.8	11.3	22.7	29.6	9.4	27.7	19.4	24.6	20.5	12.5	14.5	17.5	18.6	6.0	10.7	11.2	10.2	10.0	31.0	18.0	48.0	18.1	16.6	16.1	10.2	22.0	23.4	25.8	25.1	5.1	16.6	21.9	18.2	37.5	7.2	15.6	15.0	11.3	8.3	11.3	7.9	17.8	29.0	12.7	14.1	49.9	33.7	23.6	10.1	32.2	18.9	14.5	30.7	13.0	19.5	19.3	28.7	31.9	38.5	21.2	41.5	18.3	7.1	23.9	22.7	9.3	16.9	10.1	18.6	16.9	14.2	13.9	20.6	7.2	20.4	9.4	20.3	22.8	23.9	22.7	19.3	24.6	29.6	20.0	18.9	19.9	2.2	19.4	27.7	15.0	17.6	20.5	10.2	13.0	18.1	13.7	10.9	8.2	16.7	13.4	12.5	12.4
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: "	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	5.6	4.7	7.3	4.7	11.2	7.2	4.9	6.3	12.0	5.4	3.5	4.9	8.9	4.4	5.2	11.9	3.7	17.4	5.7	3.7	6.6	3.9	4.5	2.5	6.7	4.6	2.8	6.4	7.0	4.9	7.1	17.8	3.7	5.4	4.5	2.9	8.3	4.1	5.7	3.7	9.6	4.5	5.3	3.5	4.6	4.3	11.4	3.7	5.8	14.9	3.7	2.6	4.3	4.5	0.5	0.4	2.6	1.0	0.5	0.8	0.4	7.5	4.2	5.6	4.4	5.1	7.4	4.4	4.0	4.1	5.6	4.4	4.0	6.7	4.0	10.0	4.5	7.1	2.8	6.8	2.8	4.9	6.4	3.3	7.7	3.6	3.5	6.6	5.2	5.9	3.4	6.6	4.2	3.9	6.1	4.3	2.5	5.6	8.0	6.6	0.9	4.5	6.9	3.6	6.5	2.5	1.0	17.9	5.5	6.2	4.6	6.6	6.1	7.2	3.5	8.1	3.4	13.3	4.8	5.2	6.8	4.0	3.4	8.3	2.1	2.6	1.0	0.0	0.5	0.2	0.8	0.3	0.5	0.0	0.4	0.5	0.4	0.0	1.4	0.5	0.8	0.3	0.2	0.4	7.3	11.2	6.3	12.0	6.6	3.9	2.8	6.4	5.4	3.7
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"			83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	17.6	14.3	24.0	13.5	11.7	14.2	18.5	13.3	38.4	16.1	13.0	40.4	11.6	23.7	26.9	11.8	16.7	16.0	8.4	17.5	16.2	13.8	20.5	12.0	11.0	17.0	32.8	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.0	0.3	1.7	1.1	0.5	1.0	0.4	0.2	0.5	2.8	1.0	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.7	0.5	0.0	0.7	0.1	0.2	0.8	6.9	0.1	0.2	0.8	0.3	0.3	3.0	2.6	0.3	0.3	0.3	1.7	2.1	0.2	0.9	1.7	11.3	0.4	0.8	3.2	0.7	1.6	0.4	0.3	1.0	0.2	3.8	0.2	5.1	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AF22: 11.0;BJ: 3.6;EFO-21: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.2	1.5	0.0	3.6	0.3	0.0	0.1	0.0	0.0	0.1	8.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.2	0.0	5.6	4.5	0.3	1.1	0.0	0.1	0.9	1.9	4.7	0.1	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	5.9	0.2	0.1	0.0	5.6	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.2	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.2	0.3	1.1	2.1	0.0	3.6	2.4	0.7	3.1	0.4	0.2	0.3	0.2	8.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.3	3.1	0.5	1.5	5.3	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.1	3.0	3.6	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.8	0.1	0.1	5.7	0.4	0.3	0.1	1.8	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	1.5	0.4	0.0	0.4	0.1	11.0	0.9	0.1	0.3	0.7	6.4	0.1	5.4	0.9	0.4	0.8	0.8	0.4	1.8	0.4	0.9	0.7	13.7	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	1.4	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.3	1.0	2.5	0.2	0.5	0.4	1.2	0.0	1.0	1.1	0.4	0.6	2.0	5.9	3.1	0.1	0.2	0.3	1.1	0.1	0.5	0.0	0.2	0.0	1.8	0.1	0.4	6.6	0.3	0.6	0.5	1.6	0.1	0.3	0.5	0.6	0.3	0.7	0.3	0.1	0.3	0.7	0.0	0.3	0.3	0.7	1.8	0.6	0.1	0.8	1.5	0.7	7.2	0.5	0.5	0.1	3.9	0.3	0.1	0.1	8.3	0.2	1.4	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: , HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: , HPA077526: "	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	1.7	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: "	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.4	0.3	13.2	10.7	0.2	1.4	2.4	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.6	0.6	0.2	0.1	1.2	0.3	1.0	0.3	0.4	0.7	1.0	0.1	0.1	1.8	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.0	0.3	0.8	0.0	6.7	0.6	0.1	0.7	0.7	0.3	2.0	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.5;TIME: 14.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.0	0.0	4.6	5.9	0.8	6.8	28.5	2.8	1.9	0.0	0.0	0.2	5.5	0.2	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	4.3	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	2.6	14.3	3.8	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2										
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.2	0.1	0.6	0.7	0.9	1.6	0.0	0.4	1.0	0.2	0.2	1.5	6.2	1.0	0.3	0.0	0.3	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.2	2.0	0.9	0.1	0.6	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.2	0.1	0.1	2.9	0.2	0.2	0.3	0.0	0.1	0.1	1.4	0.4	2.9	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.8	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 42.5;HSkMC: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	42.5	1.0	0.2	0.4	2.8	0.3	1.0	2.1	0.0	2.6	0.3	2.3	5.6	0.7	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	3.2	0.2	0.0	13.5	0.3	0.8	0.4	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	4.7	0.9	0.0	0.1	0.0	4.6	6.3	0.1	0.0	0.0	0.4	0.4	5.5	5.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 112.7"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Low region specificity"	"Detected in some"			"HPA053810, HPA065621, HPA078004"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA053810: , HPA065621: , HPA078004: "			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	112.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA031975, HPA040616"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: "	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.0	0.0	0.5	2.7	10.5	14.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.7	0.0	0.3	0.0	23.4	5.5	3.3	0.0	0.0	0.0	0.1	2.7	0.7	3.2	0.0	0.2	1.6	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.1	0.0	3.2	8.1	0.0	0.1	0.0	0.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	14.9	0.1	9.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"			11000	"Lipid droplets, Plasma membrane"	"Vesicles, Cytosol"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: "	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.4	18.0	11.1	12.2	6.1	5.3	25.4	8.5	3.9	11.4	14.5	7.6	10.0	9.1	12.6	5.8	5.9	14.9	12.0	21.3	22.2	30.7	12.8	20.2	28.9	6.0	16.5	11.5	3.1	10.8	12.7	10.3	12.7	19.9	12.5	9.7	77.6	23.3	23.0	3.0	16.7	15.1	17.6	17.2	6.9	9.7	13.8	12.8	6.8	3.3	12.8	10.1	17.5	4.0	9.6	25.6	8.7	10.3	11.8	43.8	26.7	9.8	16.3	11.0	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Group enriched"	"Detected in all"	5	"amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"				Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: , HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.8	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.1	3.7	4.7	2.6	0.0	3.8	0.0	1.2	0.0	39.8	0.1	7.4	0.1	1.5	0.2	5.7	35.6	0.6	0.3	0.2	0.2	0.2	1.2	9.6	0.0	0.1	7.6	15.7	0.6	1.0	3.5	0.0	20.5	0.4	0.1	0.1	0.7	0.0	0.1	3.0	1.3	9.0	0.3	0.0	0.7	0.0	3.4	5.1	2.4	2.0	0.6	10.8	0.8	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: , HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.8	21.1	5.6	12.1	4.3	5.1	12.4	10.0	6.0	10.4	8.1	22.9	14.7	17.4	13.0	6.3	20.4	15.4	11.6	7.0	9.4	18.5	13.4	7.9	17.8	7.2	20.9	17.7	5.3	16.4	25.6	23.7	5.8	19.2	11.7	5.9	20.5	14.1	13.5	24.2	14.3	15.6	7.7	17.2	7.2	8.8	7.6	16.2	8.0	7.7	10.0	18.6	10.9	7.6	7.0	12.0	15.6	31.5	23.9	20.8	20.5	10.0	26.9	7.4	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905214-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"				"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favourable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	17.3	16.5	17.1	16.0	21.7	10.2	18.4	16.5	28.2	19.5	13.2	46.3	21.1	19.3	16.3	20.4	22.0	37.2	19.4	8.5	19.3	19.5	19.9	21.5	19.3	13.9	22.1	14.6	23.7	28.0	12.7	23.2	24.2	27.6	19.5	9.8	21.4	41.1	21.4	9.1	19.2	18.9	12.1	42.1	17.2	21.8	15.9	20.3	10.3	23.8	10.6	18.2	15.7	13.9	6.4	14.2	2.5	5.9	7.1	5.0	3.7	22.8	22.9	10.4	25.4	21.0	13.1	12.5	14.9	13.9	16.3	19.9	18.6	22.1	9.4	14.5	11.9	27.4	9.9	15.1	6.1	14.8	8.9	6.5	8.1	17.8	27.0	6.5	10.1	20.1	9.6	14.2	8.6	11.1	14.8	10.7	9.4	27.4	8.7	12.7	17.1	7.7	10.9	7.6	14.2	20.1	20.3	14.8	19.5	9.4	22.7	12.4	22.1	17.1	11.8	20.1	13.9	35.9	15.7	26.0	25.6	8.4	26.6	11.0	12.9	1.9	5.2	2.0	5.0	5.9	2.7	6.4	3.5	3.2	5.7	4.6	2.1	3.7	2.5	7.1	5.0	14.2	2.7	3.7	17.1	21.7	16.5	28.2	19.3	19.5	22.1	14.6	27.6	20.3
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"			50000	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: "	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	22.4	35.7	16.9	7.5	19.0	0.6	23.2	23.6	18.5	22.5	20.5	16.8	14.0	5.3	23.6	16.8	11.1	17.1	19.0	19.3	17.7	14.3	12.9	8.9	17.3	9.0	21.5	12.9	59.3	12.9	8.7	23.1	31.9	15.0	15.6	9.7	11.2	11.9	22.7	6.1	3.5	8.0	28.1	20.9	15.8	11.2	13.2	17.5	2.9	15.4	6.9	4.4	22.7	16.1	9.2	0.3	0.6	0.1	1.4	2.9	0.5	3.8	12.0	12.2	19.7	19.4	36.5	2.2	14.5	29.3	12.4	18.8	7.5	22.8	3.6	20.7	25.6	2.5	18.3	6.4	16.9	0.6	9.9	0.3	11.8	8.1	15.2	1.1	0.0	29.4	9.0	18.2	23.8	8.7	0.0	28.8	14.4	12.0	0.0	0.0	9.3	9.5	5.4	15.1	7.6	24.0	3.8	7.7	6.2	0.0	16.1	18.4	5.6	0.1	0.0	39.2	13.1	3.6	22.4	14.9	18.5	4.4	14.6	0.0	22.0	0.6	0.1	0.1	2.9	0.1	1.2	6.4	0.9	1.4	0.1	9.2	0.3	1.0	0.5	1.4	0.1	0.3	0.2	0.5	16.9	19.0	23.6	18.5	17.7	14.3	21.5	12.9	15.0	17.5
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: , HPA067637: "	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.7	1.4	0.0	0.1	3.8	0.0	0.3	1.4	0.0	18.9	9.8	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.7	0.0	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: "	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	10.6	10.0	8.6	13.8	9.6	4.8	11.0	16.3	11.8	9.9	10.8	9.6	9.6	11.5	15.3	8.7	6.3	10.1	7.1	11.0	6.3	6.1	6.1	7.4	8.5	10.4	7.4	6.7	15.5	21.7	5.4	11.3	7.7	9.2	10.1	8.3	10.7	14.1	15.5	19.3	10.6	12.9	10.0	9.2	10.0	7.6	9.2	8.2	12.8	9.1	5.6	12.2	10.8	12.8	6.1	6.3	11.5	4.3	4.1	7.9	3.0	6.0	11.3	11.4	8.1	7.8	5.4	13.3	9.8	5.7	10.5	10.8	18.0	5.2	16.1	6.7	4.0	11.7	10.8	6.4	13.1	4.6	10.9	5.9	12.0	4.8	3.9	5.9	5.8	3.8	5.8	10.7	9.5	5.1	6.1	6.3	8.1	3.7	10.9	4.2	5.2	5.6	13.5	5.8	4.1	4.2	7.3	4.7	6.5	9.1	3.8	9.4	5.5	3.7	5.0	10.3	5.3	8.6	8.5	4.4	5.9	5.8	5.8	5.3	10.0	11.5	3.6	3.2	7.9	4.3	6.5	6.1	4.6	5.0	2.1	3.8	5.3	7.6	2.1	4.1	3.3	6.3	4.8	3.0	8.6	9.6	16.3	11.8	6.3	6.1	7.4	6.7	9.2	8.2
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.8;TIME: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favourable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.2	2.0	3.7	3.5	11.1	4.0	3.5	3.5	5.9	3.8	3.8	2.7	4.7	5.1	2.8	4.4	2.1	4.3	7.5	4.0	5.9	3.5	5.9	3.7	3.1	5.8	6.6	6.6	4.4	5.2	4.3	7.4	50.8	2.6	6.0	3.5	1.7	6.6	5.8	4.1	9.1	4.6	2.7	5.4	9.9	5.6	2.6	5.5	3.0	3.3	4.2	2.2	8.4	29.5	3.4	3.4	3.9	4.1	9.7	6.9	4.4	2.4	7.9	4.8	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.1	7.5	4.7	1.7	7.9	13.8	12.7	10.1	13.7	17.8	9.9	9.9	9.8	9.8	8.7	3.8	26.7	8.1	8.9	10.6	16.9	11.0	4.6	14.4	6.3	13.0	14.6	8.4	8.2	15.0	11.4	7.2	10.5	16.3	20.7	9.0	12.8	13.5	5.0	19.1	10.2	3.8	15.2	11.4	14.9	13.5	12.9	13.6	10.7	16.1	14.0	13.4	14.1	7.4	12.3	21.0	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: , HPA074049: "	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	17.2	18.0	9.8	3.2	7.4	3.8	21.1	7.0	5.8	7.1	8.8	29.3	15.4	1.0	22.9	6.0	12.9	7.4	16.7	3.5	5.2	7.9	7.1	19.7	3.2	2.7	0.7	4.2	4.0	17.0	10.0	11.3	0.1	0.8	8.7	5.5	14.7	0.2	3.9	7.8	4.3	4.2	19.7	9.9	17.3	8.7	3.2	3.2	36.8	17.7	7.8	15.6	4.6	0.5	0.9	10.8	1.0	19.0	3.4	4.3	1.4	10.4	5.9	4.1	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.2	24.3	9.2	21.4	17.7	9.8	26.3	11.5	11.9	19.2	17.2	22.2	24.7	6.6	28.4	10.3	21.8	14.9	12.7	6.9	7.5	25.3	9.5	23.7	27.5	30.1	10.5	20.6	16.4	17.1	20.7	8.8	17.7	21.3	11.9	9.6	27.4	11.5	30.1	21.8	16.1	14.6	11.1	29.3	10.4	10.0	16.5	21.4	8.2	24.5	17.9	24.4	12.8	14.9	15.7	11.9	21.8	8.8	18.0	14.1	6.1	20.1	16.1	12.6	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA030620: AB_10601598, HPA077020: "	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.5	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.0	0.2	8.9	1.3	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.1	11.6	0.0	4.7	0.4	0.1	0.6	0.1	0.5	0.4	1.7	0.0	0.1	1.4	0.2	0.0	0.0	0.6	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: "	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UNC13B	"hmunc13, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"				Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: "	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favourable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favourable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favourable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favourable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	11.9	12.1	9.3	9.0	18.3	1.4	10.4	16.6	18.8	12.2	21.4	10.1	35.0	11.5	10.6	8.4	14.9	11.1	14.6	11.1	9.2	7.1	22.1	21.5	37.6	2.2	9.5	9.5	7.9	28.7	21.7	13.7	6.3	10.1	20.5	25.1	27.2	20.7	33.6	21.1	14.6	13.0	12.2	9.4	5.0	15.8	16.2	9.1	0.8	12.5	11.6	5.8	8.6	10.4	0.9	1.9	0.0	0.4	0.0	0.3	0.4	5.4	7.3	8.1	13.0	15.7	8.8	6.9	8.9	4.1	6.6	9.0	6.0	2.5	0.0	4.1	11.6	2.6	20.4	10.4	8.5	0.0	6.5	3.3	20.7	7.7	7.6	1.2	3.8	6.9	8.2	10.5	10.9	21.4	7.4	4.7	7.8	4.2	1.1	0.1	7.3	7.7	0.0	5.0	1.9	9.1	7.1	8.7	9.2	6.3	3.9	6.5	6.7	4.2	19.6	4.6	4.3	7.1	6.8	7.4	8.8	0.0	5.0	10.4	4.6	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.3	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	9.3	18.3	16.6	18.8	9.2	7.1	9.5	9.5	10.1	9.1
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"				"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: , HPA043947: "	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favourable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.7	6.3	11.2	7.3	11.6	16.3	9.6	8.7	6.7	8.9	5.4	7.4	12.6	13.3	4.6	12.5	10.7	8.8	10.5	9.9	9.9	8.5	15.6	10.0	6.6	13.9	21.0	17.0	11.4	20.6	6.0	9.9	8.9	11.5	11.8	17.0	4.9	15.3	21.1	10.6	3.3	16.0	6.3	8.1	15.6	9.9	5.7	12.0	6.2	14.8	13.2	8.6	35.0	13.8	5.7	6.9	5.6	9.8	8.8	11.0	14.1	5.9	14.9	13.2	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: "	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	38.8	34.7	47.1	35.3	21.4	28.7	34.7	43.0	27.7	45.2	38.8	46.1	29.2	57.0	30.1	29.4	33.0	71.8	29.8	66.7	34.8	26.4	56.1	35.8	28.8	15.5	56.5	38.4	16.2	22.3	35.7	39.0	36.9	64.7	33.3	41.6	20.4	47.0	24.8	54.8	26.6	42.1	53.8	34.6	20.6	29.5	37.7	20.0	41.8	35.4	20.9	28.9	27.9	24.6	42.5	48.3	34.6	42.2	27.0	44.6	82.7	26.4	48.5	38.3	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: , HPA073622: "	"prognostic unfavourable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.12e-5)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.4	7.7	10.0	7.9	24.0	26.0	9.1	39.2	26.6	17.7	28.6	12.2	12.1	6.3	18.9	42.5	10.6	9.5	19.2	23.9	8.8	8.3	4.6	13.4	12.4	19.4	10.3	7.7	19.6	18.0	15.8	13.0	16.7	4.9	10.6	23.8	6.0	5.0	5.9	6.4	8.4	5.4	14.9	10.4	11.0	10.2	6.8	8.4	13.6	7.3	17.4	15.2	6.8	64.4	20.9	10.1	20.1	15.4	9.7	15.9	8.0	19.9	9.9	15.1	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: "	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.3	10.6	4.7	11.2	4.6	3.8	5.9	6.2	2.5	3.3	3.8	3.4	7.0	4.1	6.1	4.0	8.2	2.2	6.8	1.3	8.5	8.2	2.9	11.7	6.6	8.8	7.0	7.6	3.7	8.5	4.6	1.7	2.4	7.4	9.2	2.1	14.5	6.5	8.6	8.1	8.1	8.8	5.5	7.5	2.6	2.3	9.8	8.5	9.3	5.6	4.4	7.3	12.1	6.0	6.7	6.1	7.5	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0